Koninklijke Philips N.V.

PHG Healthcare Medical Devices

Koninklijke Philips N.V.’s revenue for fiscal 2025 (year ended December 2025) was $20.2 billion, up 3.47% from fiscal 2024. In the quarter to June 2026, revenue grew 2.94%, EPS grew 56.7%, free cash flow grew 49.7% and total debt fell 9.93%, each against the same quarter a year earlier.

25.74 0.25 +0.98%
Market cap
$24.9B
P/E
18.8×
Fwd P/E
11.2×
Dividend yield
3.94%
F-score
7/9
Altman Z
1.98
Beneish M
−2.68
Dividend safety
55/100
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
24.87 27.23 0.00 0.00 4.69 27.57 18.34 13.30 18.53 17.44
Piotroski F-Score
7 5 5 3 4 6 5 7 6 7
P/S ratio
1.27 1.22 0.87 0.61 1.34 1.78 1.33 1.16 1.63 1.02
Altman Z-Score
1.98 1.71 1.61 1.25 2.17 3.07 3.10 2.62 2.93 2.25
Altman Z″-Score (non-manufacturers)
2.10 1.70 1.67 1.69 2.64 2.91 2.93 2.81 3.30 2.71
P/FCF ratio
44.24 0.00 0.00 0.00 9.58 12.69 14.98 12.62 22.97 23.33
Beneish M-Score
(2.68) (2.82) (2.90) (2.78) (2.53) (2.88) (2.54) (2.48) (2.85) (2.57)
P/Operating CF
16.23 (267.60) 58.01 37.61 30.17 19.99 24.51 18.06 87.62 23.41
Dividend Safety Score
55 — — — — — — — — —
P/B ratio
2.07 1.84 1.61 1.02 2.04 3.50 3.17 2.33 2.49 1.85
Price to Tangible BV
0.00 0.00 0.00 0.00 195.21 48.32 83.41 0.00 31.55 23.66
EV/Sales
1.50 1.51 1.14 0.89 1.53 1.89 1.44 1.23 1.75 1.08
EV/EBITDA
10.50 17.61 35.24 8.00 8.40 9.57 9.49 7.48 14.37 8.34
EV/Operating CF
22.83 308.66 21.71 12.20 7.31 9.67 11.26 9.39 15.42 13.93
EV/FCF
52.15 (23.53) (144.01) (690.86) 10.93 13.45 16.31 13.40 24.70 24.71
Quick Ratio
0.86 0.84 0.71 0.71 0.85 0.99 0.88 0.80 0.88 0.77
Current Ratio
1.32 1.23 1.20 1.29 1.39 1.45 1.36 1.21 1.47 1.34
Net Debt/EBITDA
1.59 2.42 4.44 4.17 2.17 0.74 1.12 0.45 0.80 0.47
Debt/Assets
25.73% 24.55% 23.92% 23.69% 20.91% 20.59% 18.28% 13.17% 15.97% 12.45%
Debt/Equity
0.63 0.59 0.58 0.55 0.45 0.48 0.39 0.28 0.34 0.30
Asset Turnover
0.65 0.62 0.61 0.54 0.59 0.72 0.72 0.72 0.62 0.77
Operating CF/Net income
1.31 (2.23) (4.58) 0.11 0.49 2.34 1.74 1.63 1.13 1.31
Capex/Depreciation
(0.59) (0.48) (0.44) (0.27) (0.55) (0.56) (0.65) (0.73) (0.66) (0.64)
Interest Coverage
4.12 1.37 (0.31) (5.92) 2.94 7.56 7.06 6.51 5.77 3.31
ROE
7.95% (5.82%) (3.73%) (10.89%) 25.56% 9.78% 9.19% 9.23% 13.13% 11.43%
ROA
3.27% (2.40%) (1.57%) (4.91%) 11.50% 4.38% 4.29% 4.34% 5.82% 4.57%
ROIC
5.91% 1.98% (0.42%) (4.96%) 1.86% 6.75% 6.37% 8.02% 6.74% 7.85%
Return on Tangible Assets
19.29% (16.22%) (11.27%) (32.40%) 59.31% 19.23% 21.83% 32.62% 34.22% 25.15%
Average Days of Receivables
73.47 88.15 79.41 88.80 84.40 80.46 88.64 84.24 82.48 81.60
Research and Development Expense of Revenue
9.53% 9.69% 10.40% 11.80% 10.53% 9.80% 9.67% 9.71% 9.92% 8.24%
Selling, General and Administrative Expense of Revenue
27.87% 28.12% 28.25% 29.62% 28.31% 27.00% 27.27% 28.32% 27.98% 27.46%
Intangible Assets out of Total Assets
0.44 0.46 0.44 0.45 0.46 0.40 0.45 0.46 0.44 0.39
Share Based Compensation of Revenue
0.79% 0.53% 0.48% 0.53% 0.63% 0.59% 0.50% 0.00% 0.00% 0.00%
Graham Net Nets
(0.27) (0.34) (0.39) (0.55) (0.22) (0.12) (0.12) (0.15) (0.11) (0.19)
Graham Number
17.92 16.63 0.00 0.00 56.46 26.17 30.38 0.00 26.39 25.18
Earnings Yield
4.02% 3.67% (9.73%) (20.07%) 21.30% 3.63% 5.45% 7.52% 5.40% 5.73%
Free Cash Flow Yield
2.26% (5.27%) (0.91%) (0.21%) 10.44% 7.88% 6.67% 7.92% 4.35% 4.29%
Revenue per Share
21.28 20.89 21.43 21.30 22.45 24.58 24.16 23.19 21.64 29.55
Operating CF per Share
1.40 1.82 2.52 (0.21) 2.13 3.49 2.52 2.28 2.28 2.30
Capex per Share
(0.79) (0.77) (0.65) (0.94) (0.96) (1.16) (1.21) (1.02) (0.83) (1.00)
Free Cash Flow per Share
0.61 1.05 1.87 (1.15) 1.18 2.33 1.31 1.26 1.44 1.29
Cash per Share
3.43 2.87 2.26 1.56 3.10 4.19 1.77 2.76 2.43 3.06
Shareholders Equity per Share
13.11 13.96 14.23 15.87 18.94 14.98 15.66 15.50 14.63 16.28
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
13.11 13.96 14.23 15.87 18.94 14.98 15.66 15.50 14.63 16.28
Free Cash Flow
580.41 980.38 1,712.20 (1,012.51) 1,063.61 2,116.68 1,179.36 1,160.92 1,340.54 1,187.38
Working Capital
2,741.38 2,030.02 1,789.04 2,449.62 3,427.45 3,988.91 2,778.72 1,923.85 3,674.61 3,985.97
Capital Expenditures
(745.59) (717.43) (599.59) (830.24) (863.66) (1,055.49) (1,095.36) (941.26) (773.13) (919.58)
Net Current Asset Value
(6,813.30) (7,478.39) (8,014.43) (7,529.03) (7,263.05) (5,237.45) (5,523.84) (5,113.73) (3,588.70) (5,223.16)
EV/EBIT
18.79 16.88 0.00 0.00 37.50 44.73 35.22 16.50 18.05 14.09
Capex to Sales
0.04 0.04 0.03 0.04 0.04 0.05 0.05 0.04 0.04 0.03
Price to Operating Income
15.94 13.62 0.00 0.00 32.86 42.21 32.37 15.54 16.79 13.30
Other line items
Depreciation/Fixed assets
0.51 0.57 0.51 1.12 0.50 0.62 0.52 0.64 0.65 0.60
Cash ROIC
2.47% 4.19% 7.53% (4.40%) 3.86% 8.85% 5.55% 5.55% 6.57% 5.35%
Accounts Receivable Turnover
4.60 4.34 4.45 4.06 4.22 4.37 4.26 4.51 3.79 4.63
Accounts Payable Turnover
5.32 5.47 5.59 5.22 5.10 5.16 4.70 4.45 3.94 5.03
Inventory Turnover
3.30 3.06 2.88 2.68 3.15 3.77 3.79 3.88 3.38 4.05
Average Days of Payables
71.95 65.18 65.26 67.56 68.41 71.92 71.89 87.85 79.46 74.76
Days of Inventory on Hand
107.16 113.90 118.85 138.99 126.08 101.59 95.42 102.01 89.46 89.04
Average Receivables
4,385.51 4,493.82 4,423.90 4,631.41 4,806.05 5,108.73 5,118.83 4,740.24 5,303.41 5,861.94
Average Payables
2,080.23 2,027.51 2,074.13 2,144.12 2,317.65 2,380.11 2,529.76 2,541.09 2,756.96 3,059.85
Average Inventory
3,353.84 3,619.43 4,022.17 4,173.86 3,750.30 3,262.33 3,131.88 2,908.80 3,206.59 3,799.45
Average Assets
30,919.69 31,590.52 32,079.50 34,481.42 34,143.26 30,957.24 30,493.18 29,671.00 32,180.03 35,071.13
Average Common Equity
12,731.78 13,043.22 13,524.31 15,559.65 15,360.52 13,867.27 14,223.94 13,949.30 14,268.78 14,014.23

Fold the line items

Columns are period end dates